English: Toxic granulation in two white blood cells, bone marrow aspiration. (Photo credit: Wikipedia)
The fast and safe technique developed at the Salk Institute circumvents problems that have hindered regenerative medicine
For the first time, scientists have turned human skin cells into transplantable white blood cells, soldiers of the immune system that fight infections and invaders. The work, done at the Salk Institute, could let researchers create therapies that introduce into the body new white blood cells capable of attacking diseased or cancerous cells or augmenting immune responses against other disorders.
The work, as detailed in the journal Stem Cells, shows that only a bit of creative manipulation is needed to turn skin cells into human white blood cells.
“The process is quick and safe in mice,” says senior author Juan Carlos Izpisua Belmonte, holder of Salk’s Roger Guillemin Chair. “It circumvents long-standing obstacles that have plagued the reprogramming of human cells for therapeutic and regenerative purposes.”
Those problems includes the long time—at least two months—and tedious laboratory work it takes to produce, characterize and differentiate induced pluripotent stem (iPS) cells, a method commonly used to grow new types of cells. Blood cells derived from iPS cells also have other obstacles: an inability to engraft into organs or bone marrow and a likelihood of developing tumors.
The new method takes just two weeks, does not produce tumors, and engrafts well.
“We tell skin cells to forget what they are and become what we tell them to be—in this case, white blood cells,” says one of the first authors and Salk researcher Ignacio Sancho-Martinez. “Only two biological molecules are needed to induce such cellular memory loss and to direct a new cell fate.”
The Latest on: Regenerative medicine
[google_news title=”” keyword=”Regenerative medicine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Regenerative medicine
- ZetrOz Systems to Showcase sam X1 at TOBI Conferenceon June 9, 2023 at 5:01 am
The Orthobiologic Institute (TOBI) and The American Society of Interventional Pain Physicians (ASIPP) are set to host a highly anticipated CME activity that serves as a platform for physicians to ...
- NC’s governor receives award for role in life sciences developmenton June 9, 2023 at 3:24 am
N.C. Governor Roy Cooper earlier this week received the Regenerative Medicine Action Leadership Award from the Regenerative Medicine Foundation, a non-profit organization that promotes the development ...
- Researchers develop promising stem cell-based regenerative therapy for heart diseaseon June 8, 2023 at 10:22 am
A stem cell therapy treatment developed by Duke-NUS Medical School researchers for heart failure has shown promising results in preclinical trials. These cells, when transplanted into an injured heart ...
- Veterinary Regenerative Medicine Market Size & Share to Surpass $1283.8 Million by 2030 | Vantage Market Researchon June 8, 2023 at 1:19 am
The Global Veterinary Regenerative Medicine Market is valued at USD 549.1 Million in 2022 and is projected to reach a value of USD 1283.8 Million by 2030 at a CAGR (Compound Annual Growth Rate) of 12.
- Duke-NUS researchers develop promising stem cell-based regenerative therapy for heart diseaseon June 7, 2023 at 5:00 pm
A stem cell therapy treatment developed by Duke-NUS Medical School researchers for heart failure has shown promising results in preclinical trials. These cells, when transplanted into an injured heart ...
- CellSave Arabia, Bioscience Institute unveil revolutionary regenerative medicine service for first time in UAEon June 7, 2023 at 2:09 am
CellSave Arabia, a leading provider of advanced stem cell solutions, announced its groundbreaking collaboration with Bioscience Institute, a renowned leader in regenerative medicine service. This hist ...
- Introducing NeoPAC™ Tissues: OrganaBio Unveils New Birth Tissue Products to Advance Regenerative Medicine and Cell Therapyon June 6, 2023 at 9:25 am
OrganaBio is thrilled to announce the launch of NeoPAC™ placenta and umbilical cord tissues, its latest suite of products designed to accelerate the progress of regenerative medicine and cell therapy.
- ‘In regenerative medicine, the new organ is never rejected’on June 5, 2023 at 6:21 am
Bioprinting pioneer and surgeon, Anthony Atala visits Spain to talk about medical research into reconstructing vital organs from their own cells ...
- Regenerative Medicine Market | 3M, Allergan plc, Amgen, Inc., Aspect Biosystems | By 2032on June 4, 2023 at 8:15 pm
The global Regenerative Medicine Market is anticipated to register a phenomenal growth of 23.9% with an evaluation of around US$ 9.9 Bn by the end of the year 2022 and is further expected to enjoy an ...
- Regenerative medicine center goes out of this world to explore human organ researchon June 2, 2023 at 3:41 am
Researchers at Wake Forest University have a new far-out location for advancing their work with human organ tissues - the International Space Station.
via Bing News
